Published in Immunology on July 01, 2014
Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity. Proc Natl Acad Sci U S A (2016) 0.81
High-throughput sequencing reveals an altered T cell repertoire in X-linked agammaglobulinemia. Clin Immunol (2015) 0.75
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Homeostasis of naive and memory T cells. Immunity (2008) 7.48
Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science (2000) 6.22
Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol (2003) 5.90
High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol (2000) 4.58
The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol (1999) 3.81
B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab. Arthritis Rheum (2004) 3.35
Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum (2003) 3.00
Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum (2005) 2.37
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med (2012) 2.36
IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev (2006) 2.29
Induction and regulation of IL-15 expression in murine macrophages. J Immunol (1996) 2.28
Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura. Blood (2007) 2.01
Transregulation of memory CD8 T-cell proliferation by IL-15Ralpha+ bone marrow-derived cells. Blood (2003) 2.00
Cutting edge: transpresentation of IL-15 by bone marrow-derived cells necessitates expression of IL-15 and IL-15R alpha by the same cells. J Immunol (2004) 1.87
Depletion of functionally active CD20+ T cells by rituximab treatment. Arthritis Rheum (2009) 1.87
Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol (1998) 1.81
Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis. Arthritis Rheum (2006) 1.77
Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood (1999) 1.71
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries. Ann Rheum Dis (2011) 1.68
Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response. Ann Rheum Dis (2007) 1.68
B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis Rheum (2006) 1.65
Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin Immunol (2006) 1.60
Regulatory T cells in immunologic self-tolerance and autoimmune disease. Int Rev Immunol (2005) 1.57
The anti-CD20 antibody rituximab reduces the Th17 cell response. Arthritis Rheum (2011) 1.51
Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum (2005) 1.49
NK cell survival mediated through the regulatory synapse with human DCs requires IL-15Ralpha. J Clin Invest (2007) 1.37
Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma. Semin Oncol (1999) 1.37
The therapeutic potential of anti-CD20 "what do B-cells do?". Clin Immunol (2005) 1.18
Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis. J Pathol (1997) 1.16
Overexpression of IL-15 in vivo enhances protection against Mycobacterium bovis bacillus Calmette-Guérin infection via augmentation of NK and T cytotoxic 1 responses. J Immunol (2001) 1.14
Disturbed Th17/Treg balance in patients with rheumatoid arthritis. Rheumatol Int (2011) 1.11
IL-15 transpresentation augments CD8+ T cell activation and is required for optimal recall responses by central memory CD8+ T cells. J Immunol (2008) 1.10
B cells, be gone--B-cell depletion in the treatment of rheumatoid arthritis. N Engl J Med (2004) 1.09
Crystal Structure of the interleukin-15.interleukin-15 receptor alpha complex: insights into trans and cis presentation. J Biol Chem (2007) 1.07
A dual action of rheumatoid arthritis synovial fibroblast IL-15 expression on the equilibrium between CD4+CD25+ regulatory T cells and CD4+CD25- responder T cells. J Immunol (2009) 1.07
Clinical significance of IL-18, IL-15, IL-12 and TNF-alpha measurement in rheumatoid arthritis. Clin Rheumatol (2005) 1.06
Interleukin 15 levels in serum may predict a severe disease course in patients with early arthritis. PLoS One (2011) 1.04
Epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am (1995) 1.02
NK and NKT cell dynamics after rituximab therapy for systemic lupus erythematosus and rheumatoid arthritis. Rheumatol Int (2008) 1.02
B-cell depletion and repopulation in autoimmune diseases. Clin Rev Allergy Immunol (2008) 0.95
B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjögren's syndrome: a double-blind, placebo-controlled study. Arthritis Rheum (2011) 0.93
The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab. Vaccine (2011) 0.90
Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia. Int J Hematol (2010) 0.89
Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies. Ann Rheum Dis (2009) 0.86
Anti-interleukin-15 prevents arthritis in Borrelia-vaccinated and -infected mice. Clin Vaccine Immunol (2006) 0.85
New strategies to control inflammatory synovitis: interleukin 15 and beyond. Ann Rheum Dis (2003) 0.83
Interleukin-15 induces interleukin-17 production by synovial T cell lines from patients with rheumatoid arthritis. Scand J Immunol (2011) 0.82
Peripheral blood T4 cell surface CCR5 density as a marker of activity in rheumatoid arthritis treated with anti-CD20 monoclonal antibody. Immunology (2009) 0.79
Predictors of response to rituximab in patients with active rheumatoid arthritis and inadequate response to anti-TNF agents or traditional DMARDs. Clin Exp Rheumatol (2011) 0.79
Rituximab therapy in Greek patients with rheumatoid arthritis. Biologics (2008) 0.77
Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals. Clin Infect Dis (2004) 1.80
Forwarding techniques for IP fragmented packets in a real 6LoWPAN network. Sensors (Basel) (2011) 1.73
Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease. Am J Med (2002) 1.56
Are there clinical or serological differences between male and female patients with primary Sjögren's syndrome? J Rheumatol (2004) 1.50
The effects of sepsis on mitochondria. J Infect Dis (2011) 1.45
Core competencies in internal medicine. Eur J Intern Med (2012) 1.39
Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia. Antimicrob Agents Chemother (2006) 1.38
Mitochondrial DNA depletion and respiratory chain enzyme deficiencies are present in peripheral blood mononuclear cells of HIV-infected patients with HAART-related lipodystrophy. Antivir Ther (2003) 1.29
Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome. Nat Clin Pract Neurol (2007) 1.29
Carbon monoxide specifically inhibits cytochrome c oxidase of human mitochondrial respiratory chain. Pharmacol Toxicol (2003) 1.24
GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis. Pharmacogenomics (2013) 1.06
A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis. Arthritis Rheum (2002) 1.03
TNF alpha production to TLR2 ligands in active IBD patients. Clin Immunol (2006) 1.02
NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma. Exp Hematol (2007) 0.94
Ustekinumab treatment of TNF antagonist-induced paradoxical psoriasis flare in a patient with psoriatic arthritis: case report and review. Dermatology (2012) 0.94
Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine. J Acquir Immune Defic Syndr (2004) 0.92
Mitochondrial studies in HAART-related lipodystrophy: from experimental hypothesis to clinical findings. Antivir Ther (2005) 0.92
Mitochondrial effects of antiretroviral therapies in asymptomatic patients. Antivir Ther (2004) 0.91
Functional consequences of CD36 downregulation by TLR signals. Cytokine (2012) 0.89
Selective loss of chemokine receptor expression on leukocytes after cell isolation. PLoS One (2012) 0.88
Effect of smoking cessation on mitochondrial respiratory chain function. J Toxicol Clin Toxicol (2003) 0.87
Skeletal muscle mitochondrial function is preserved in young patients with chronic renal failure. Am J Kidney Dis (2002) 0.86
Mitochondrial DNA depletion in oocytes of HIV-infected antiretroviral-treated infertile women. Antivir Ther (2008) 0.85
Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis. Dig Dis Sci (2014) 0.85
Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype. World J Gastroenterol (2007) 0.84
Comparative effectiveness of rituximab in combination with either methotrexate or leflunomide in the treatment of rheumatoid arthritis. Semin Arthritis Rheum (2011) 0.84
VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosis. Liver Int (2014) 0.82
Interleukin-15 enhances rituximab-dependent cytotoxicity against chronic lymphocytic leukemia cells and overcomes transforming growth factor beta-mediated immunosuppression. Exp Hematol (2011) 0.82
Microbiome composition by pyrosequencing in mesenteric lymph nodes of rats with CCl4-induced cirrhosis. J Innate Immun (2013) 0.82
Polymorphisms in genes involved in the mechanism of action of methotrexate: are they associated with outcome in rheumatoid arthritis patients? Pharmacogenomics (2014) 0.82
Functional consequences of platelet binding to T lymphocytes in inflammation. J Leukoc Biol (2013) 0.81
Flow cytometry analysis of leukocytes in induced sputum from asthmatic patients. Immunobiology (2011) 0.81
Heritability of bone mineral density in a multivariate family-based study. Calcif Tissue Int (2014) 0.79
In vivo effects of highly active antiretroviral therapies containing the protease inhibitor nelfinavir on mitochondrially driven apoptosis. Antivir Ther (2005) 0.79
Longitudinal study on mitochondrial effects of didanosine-tenofovir combination. AIDS Res Hum Retroviruses (2006) 0.79
Naive CD4+ cells from cord blood can generate competent Th effector cells. Transplantation (2005) 0.78
Bronchial inflammation, respiratory symptoms and lung function in Primary Sjögren's syndrome. Arch Bronconeumol (2011) 0.78
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis. Arthritis Res Ther (2014) 0.78
Short communication metabolic and mitochondrial effects of switching antiretroviral-experienced patients to enfuvirtide, tenofovir and saquinavir/ritonavir. Antivir Ther (2006) 0.78
Effect of long-term acid gastric inhibition on bacterial translocation in cirrhotic rats. Eur J Gastroenterol Hepatol (2015) 0.77
Sex-specific regulation of mitochondrial DNA levels: genome-wide linkage analysis to identify quantitative trait loci. PLoS One (2012) 0.77
Ability of physiological parameters versus clinical categories to predict mortality on admission to an internal medicine ward. Eur J Intern Med (2009) 0.77
[Is DAS a profitable score to be used for rheumatoid arthritis patient follow up?]. Reumatol Clin (2011) 0.77
[False-negative bone scintigraphy in a woman with bone metastases secondary to endometrial adenocarcinoma]. Med Clin (Barc) (2003) 0.76
Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med (2003) 0.76
[Ex vivo analysis of mitochondrial function in patients attended in an emergency department due to carbon monoxide poisoning]. Med Clin (Barc) (2004) 0.76
Short communication: reversible mitochondrial respiratory chain impairment during symptomatic hyperlactatemia associated with antiretroviral therapy. AIDS Res Hum Retroviruses (2003) 0.76
Mitochondrial DNA and nucleoside toxicity. N Engl J Med (2002) 0.76
Appropriateness of medications prescribed to elderly patients with advanced heart failure and limited life expectancy who died during hospitalization. Drugs Aging (2014) 0.76
["Seronegative" myasthenia gravis and antiMuSK positive antibodies: description of Spanish series]. Med Clin (Barc) (2005) 0.76
Usefulness of angioplasty in a patient with biopsy-proven giant cell arteritis and severe stenosis of the superior mesenteric artery. J Rheumatol (2006) 0.76
Short communication: HIV infection, antiretrovirals, and apoptosis: studies on skeletal muscle. AIDS Res Hum Retroviruses (2005) 0.75
[Critical evaluation of clinical practice guidelines]. Med Clin (Barc) (2008) 0.75
[Dermatomyositis, lipodystrophy and insulin resistance]. Med Clin (Barc) (2007) 0.75
I591T MEFV mutation in a Spanish kindred: is it a mild mutation, a benign polymorphism, or a variant influenced by another modifier? Hum Mutat (2002) 0.75
Peripheral neuropathy with ataxia in childhood as a result of the G8363A mutation in mitochondrial DNA. Pediatr Res (2004) 0.75
[Treatment of atrial fibrillation at different levels of health care]. Med Clin (Barc) (2007) 0.75
[Effort intolerance in a 24-year-old male]. Med Clin (Barc) (2005) 0.75
[Influence of patients' age in the probabilistic models of mortality on admission in general internal medicine wards]. Med Clin (Barc) (2011) 0.75
A Different Approach to the Use of C-Reactive Protein and Procalcitonin in Postoperative Infectious Complications. Ann Surg (2017) 0.75
Noninvasive diagnosis of mitochondrial dysfunction in HAART-related hyperlactatemia. Clin Infect Dis (2006) 0.75